These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7525920)
1. Diabetes-induction reduction in the hepatic accumulation of 70-kDA dextran: role of hyperglycemia and hypoinsulinemia. Mehvar R; Reynolds J J Pharm Sci; 1994 Jul; 83(7):1020-5. PubMed ID: 7525920 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of 70-kilodalton fluorescein-dextran in experimental diabetes mellitus. Mehvar R; Reynolds JM J Pharmacol Exp Ther; 1993 Feb; 264(2):662-9. PubMed ID: 7679734 [TBL] [Abstract][Full Text] [Related]
3. Disposition of fluorescein-labelled dextran (150 kD) in isolated perfused livers from control and diabetic rats. Mehvar R; Reynolds JM; Shepard TL Life Sci; 1991; 49(23):1699-706. PubMed ID: 1719328 [TBL] [Abstract][Full Text] [Related]
4. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. Rossetti L; Giaccari A; Barzilai N; Howard K; Sebel G; Hu M J Clin Invest; 1993 Sep; 92(3):1126-34. PubMed ID: 8397219 [TBL] [Abstract][Full Text] [Related]
5. Kinetics of hepatic accumulation of dextrans in isolated perfused rat livers. Mehvar R Drug Metab Dispos; 1997 May; 25(5):552-6. PubMed ID: 9152593 [TBL] [Abstract][Full Text] [Related]
7. Opposite effects of hyperglycemia and insulin deficiency on liver glycogen synthase phosphatase activity in the diabetic rat. Lavoie L; Dimitrakoudis D; Marette A; Annabi B; Klip A; Vranic M; van de Werve G Diabetes; 1993 Feb; 42(2):363-6. PubMed ID: 8381096 [TBL] [Abstract][Full Text] [Related]
8. Effects of insulin on blood, plasma, and brain glucose in hyperglycemic diabetic rats. Hofer RE; Lanier WL Stroke; 1991 Apr; 22(4):505-9. PubMed ID: 1902600 [TBL] [Abstract][Full Text] [Related]
9. Molecular weight dependent tissue accumulation of dextrans: in vivo studies in rats. Mehvar R; Robinson MA; Reynolds JM J Pharm Sci; 1994 Oct; 83(10):1495-9. PubMed ID: 7533835 [TBL] [Abstract][Full Text] [Related]
10. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production. Barzilai N; Hawkins M; Angelov I; Hu M; Rossetti L Diabetes; 1996 Oct; 45(10):1329-35. PubMed ID: 8826967 [TBL] [Abstract][Full Text] [Related]
11. Insulin-induced normoglycemia improves ischemic outcome in hyperglycemic rats. Warner DS; Gionet TX; Todd MM; McAllister AM Stroke; 1992 Dec; 23(12):1775-80; discussion 1781. PubMed ID: 1448829 [TBL] [Abstract][Full Text] [Related]
12. Dose dependency of the kinetics of dextrans in rats: effects of molecular weight. Mehvar R; Robinson MA; Reynolds JM J Pharm Sci; 1995 Jul; 84(7):815-8. PubMed ID: 7562429 [TBL] [Abstract][Full Text] [Related]
13. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia. Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171 [TBL] [Abstract][Full Text] [Related]
14. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats. Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941 [TBL] [Abstract][Full Text] [Related]
15. Antidiabetic effect of diasulin, a herbal drug, on blood glucose, plasma insulin and hepatic enzymes of glucose metabolism in hyperglycaemic rats. Pari L; Saravanan R Diabetes Obes Metab; 2004 Jul; 6(4):286-92. PubMed ID: 15171753 [TBL] [Abstract][Full Text] [Related]
16. The effect of chronic dexamethasone-induced hyperglycemia and its acute treatment with insulin on brain glucose and glycogen concentrations in rats. Thompson MD; Gallagher WJ; Iaizzo PA; Lanier WL Anesthesiology; 2000 Nov; 93(5):1279-84. PubMed ID: 11046217 [TBL] [Abstract][Full Text] [Related]
17. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus. Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of glucose, glycogen, and high-energy phosphates during transient forebrain ischemia in diabetic rats: effect of insulin treatment. Lanier WL; Hofer RE; Gallagher WJ Anesthesiology; 1996 Apr; 84(4):917-25. PubMed ID: 8638847 [TBL] [Abstract][Full Text] [Related]
19. In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin-dependent diabetes induced by streptozocin. Assessment with the insulin-glucose clamp technique. Kergoat M; Portha B Diabetes; 1985 Nov; 34(11):1120-6. PubMed ID: 3899811 [TBL] [Abstract][Full Text] [Related]
20. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats. Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]